Product logins

Find logins to all Clarivate products below.


BioWorld

Award-winning biopharma and medtech news

BioWorld Science

Discovery and preclinical research news to support crucial drug R&D decisions at the earliest stages.

  • Website access to BioWorld Science content
  • Full editions delivered every business day by noon ET plus breaking news bulletins
  • 14 days free

BioWorld

The news source of record covering the development of innovative human therapies for 30 years.

  • Website access to BioWorld content
  • Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
  • 14 days free

BioWorld MedTech

The news source of record covering the latest advances in medical technology.

  • Website access to BioWorld MedTech content
  • Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
  • 14 days free

BioWorld Premium

Get it all! Full-site access (excluding BioWorld Science) plus e-newsletters

  • Full website access for all three news services
  • Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
  • 14 days free

 

Be the most informed person in the room.

Stay on top of daily news, pharmaceutical and medtech industry trends, mergers and acquisitions, and the latest news on leading vaccine companies.

Choose the subscription option that works best for your needs and try it for free for 2 weeks.

 

Industry insiders have been using BioWorld's award winning content for 30 years

Best series of articles on one topic
Transforming drug, med-tech R&D with AI
News July 18, 2024
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards

Recognized for excellence in writing, news, mental health, financial/investment and economics categories London, U.K. July 18, 2024. BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,…

Blog
Trump administration impacts on healthcare and science
President Trump’s administration has introduced seismic changes that impact the global life sciences sector. Some of those impacts are already clear, but many others are moving targets. Ranging from tariffs to policy changes that are destabilizing the healthcare and science landscapes, BioWorld’s trusted reporting and analysis provides the perspective you need to succeed in uncertain times.
Unbiased and insightful

Deeply experienced journalists cut through the clutter to deliver unbiased, critical news and analysis, enriched with insightful data from Cortellis, the comprehensive suite of life science intelligence solutions from Clarivate.

Zero in on industry trends

With writers and editors stationed around the globe and at key industry conferences, BioWorld zeros in on breaking news and emerging trends. Regulatory reports help you manage the hurdles that both challenge and guard the processes to bring new therapies to market.

Global market intelligence at your fingertips

In addition to the daily news reporting, BioWorld includes two decades’ worth of pharma and biotech news archives. With a quick search, you’ll have instant access to a wealth of global market intelligence.

Daily market snapshots

Take advantage of BioWorld Snapshots – exclusive online summaries updated daily with market data such as collaborations, mergers, acquisitions, financings, market cap rankings, and more.

Get a premium subscription to access biopharma and medtech news

BioWorld Premium covers the entire drug and medical device lifecycle news around the world for $500/month*